Safety and Feasibility of Lin- Cells Administration to ALS Patients: A Novel View on Humoral Factors and miRNA Profiles

Therapeutic options for amyotrophic lateral sclerosis (ALS) are still limited. Great hopes, however, are placed in growth factors that show neuroprotective abilities (e.g., nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), and vascular endothelial growth factor (VEGF)) and in the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Mol Sci
Autori principali: Sobuś, Anna, Baumert, Bartłomiej, Litwińska, Zofia, Gołąb-Janowska, Monika, Stępniewski, Jacek, Kotowski, Maciej, Pius-Sadowska, Ewa, Kawa, Miłosz P., Gródecka-Szwajkiewicz, Dorota, Peregud-Pogorzelski, Jarosław, Dulak, Józef, Nowacki, Przemysław, Machaliński, Bogusław
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5983708/
https://ncbi.nlm.nih.gov/pubmed/29702606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19051312
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi